Survey on Grant and Publication of Supplemental Protection Certificates and Patent Term Extensions

Collated results (2019)

This survey relates to mechanisms that enable owners of patents under certain conditions to obtain, during a limited period, continued protection for certain products that are subject to pre-market regulatory approval, namely supplementary protection certificates (SPCs) and patent term extensions (PTEs).

  • Purpose: update the information in Part 7.7 of the WIPO Handbook
  • Conducted: Nov 2018 to April 2019
  • Survey approved: sixth session of the Committee on WIPO Standards (CWS)
  • Results approved: seventh session of the CWS

Notes

  • This data is presented as provided by the respondent. If you have questions about a particular respondent's data, please contact that Office for more information.
  • You can hover on an ST.3 code to see the name of the country or organization.
  • Empty table cells mean that the respondent did not answer that part of the question. Likewise, a respondent with no entry on a particular question means they did not answer that question.

Survey contents

Survey respondents

ST.3 Code Country or Office
AU

Australia

BE

Belgium

BR

Brazil

CA

Canada

CH

Switzerland

CN

China

CO

Colombia

CR

Costa Rica

CZ

Czech Republic

DE

Germany

DO

Dominican Republic

EA

Eurasian Patent Organization (EAPO)

EE

Estonia

ES

Spain

FR

France

GB

United Kingdom

HR

Croatia

IT

Italy

JP

Japan

KR

Republic of Korea

MD

Republic of Moldova

RU

Russian Federation

SE

Sweden

SK

Slovakia

UA

Ukraine

US

United States of America

1. Does your Office/Organization provide SPCs or PTEs?

ST.3 Code Response
AU

Yes

BE

Yes

BR

No

CA

Yes

CH

Yes

CN

No

CO

Yes

CR

Yes

CZ

Yes

DE

Yes

DO

Yes

EA

Yes

EE

Yes

ES

Yes

FR

Yes

GB

Yes

HR

Yes

IT

Yes

JP

Yes

KR

Yes

MD

Yes

RU

Yes

SE

Yes

SK

Yes

UA

Yes

US

Yes

2. If you have answered “NO” to Question 1, will your Office/Organization start providing SPCs or PTEs in the future?

ST.3 Code Response Comments
AU
BE
BR

No.

Until now INPI-BR was not invited to participate in any discussions about the creation of this kind of protection. It is not an INPI prerogative the legislative creation of this kind of protection.

CA
CH
CN

No.

CO
CR
CZ
DE
DO
EA
EE
ES
FR
GB
HR
IT
JP
KR
MD
RU
SE
SK
UA
US

3. Please specify for which products an SPC or PTE can be obtained (or are planned to be introduced)

ST.3 Code Response
AU

pharmaceutical substances per se

BE

medicinal products

plant protection products

BR
CA

medicinal products

CH

medicinal products

plant protection products

CN
CO

Para todos los productos y procesos en todos los campos de la tecnología, excepto para los productos farmacéuticos

CR

medicinal products

Todos los productos y procedimientos.

CZ

medicinal products

plant protection products

DE

medicinal products

plant protection products

DO

medicinal products

plant protection products

EA

medicinal products

plant protection products

EE

medicinal products

plant protection products

ES

medicinal products

plant protection products

FR

medicinal products

plant protection products

GB

medicinal products

plant protection products

HR

medicinal products

plant protection products

IT

medicinal products

plant protection products

JP

medicinal products

plant protection products

KR

medicinal products

plant protection products

MD

medicinal products

RU

medicinal products

plant protection products

SE

medicinal products

plant protection products

SK

medicinal products

plant protection products

UA

medicinal products

plant protection products

animal protection products

US

medicinal products

We only grant PTEs for products regulated under specific statutes that either FDA or USDA implements.

3a. Please describe the requirements for granting SPCs or PTEs. Examples:  the product has been protected by a patent, the product has been subject to a regulatory review procedure before its commercial marketing or use, an SPC or PTE has never been granted on the product. If available, please provide a link to guidelines on filing applications for SPCs or PTEs.

ST.3 Code Response
AU

PATENTS ACT 1990 - see - SECT 70 Applications for extension of patent

BE

https://economie.fgov.be/fr/themes/propriete-intellectuelle/brevets/demande-de-brevet/certificats-complementaires-de

BR
CA

A CSP may be granted on application to Health Canada if: The applicant is the patentee and is recorded as an owner of the patent in the Patent Office or is the manufacturer who is authorized to file on their behalf; the patent is issued and in force at the time of filing and issuance; the patent contains a claim for: the medicinal ingredient (in the case of a drug containing only one medicinal ingredient) or combination of all the medicinal ingredients (in the case of a drug containing more than one medicinal ingredient) in a drug, including in product-by-process form or a use of the medicinal ingredient (in the case of a drug containing only one medicinal ingredient) or combination of all the medicinal ingredients (in the case of a drug containing more than one medicinal ingredient) in a drug; the above drug is approved by Health Canada via a Notice of Compliance (NOC); the NOC: issued on or after September 21, 2017, is the first approval issued with respect to the single medicinal ingredient or combination, as the case may be, or a prescribed variation thereof, issued from a submission filed within twelve months of the filing of the first application for marketing approval of the medicinal ingredient or combination in the European Union or any member country thereof, U.S., Australia, Switzerland and Japan (the transitional provision has now expired); the CSP application is filed with Health Canada within 120 days of the later of the date of grant of the NOC and patent grant date (if the patent is granted after the NOC grant date); the prescribed fee is paid; no prior CSP has issued for the medicinal ingredient or combination of medicinal ingredients or a prescribed variation thereof; there is no conflict with a competing application, or the conflict has been resolved; the application sets out the  patent number, the medicinal ingredient or combination of medicinal ingredients and the number of the authorization for sale in relation to which the certificate is sought, and; the application also contains the applicant's name and contact information in Canada, including their complete address; the filing date of the application for the patent (must be on or after October 1, 1989), the date on which the patent was granted and the date of which the term of the patent will expire, and a description of the method of payment used to pay the prescribed fee. Health Canada Guidance Document - Certificate of Supplementary Protection Regulations https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/register-certificates.html o Comments: The CIPO Patent Office does not provide SPCs or PTEs.& That responsibility lies with Health Canada and Health Canada will continue to carry this responsibility in the future.  In the survey, "Office/Organization" refers to Health Canada.

CH

Art. 140b Swiss Patents Act: The certificate is granted if, at the time of the application: the product as such, a process for manufacturing it or a use of it is protected by a patent; official authorisation has been granted for placing the product on the market in Switzerland as a medicinal product. It is granted based on the first authorisation. Art. 140c para. 2:  Only one certificate shall be granted for each product.

CN
CO

Decreto 1873 de 2014. https://www.wipo.int/edocs/lexdocs/laws/es/co/co108es.pdf

CR

Si el RPI demora en otorgar la patente, el solicitante puede requerir la compensación en el plazo de vigencia de la patente, según lo dispone el art. 17.2 de la Ley N° 6867. La solicitud deberá formularse por escrito dentro de los 3 meses siguientes al otorgamiento de la patente. En el caso de productos farmacétuicos ver art. 17.4 de la misma ley.

CZ

The product has been protected by a patent. The product has been subject to a regulatory review procedure before its commercial marketing and use. An SPC has never been granted on the product. Link: https://www.upv.cz/en/ip-rights/supplementary-protection-certificates.html

DE

Substantive requirements for the grant of an SPC in the European Union are laid down in Article 3, procedural requirements in Articles 7-9 of Regulations (EC) No 469/2009 (medicinal products; https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32009R0469&from=DE ) and (EC) No 1610/96 (plant protection products; https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:31996R1610&from=DE ) respectively. Examination Guidelines (English version) for the German Patent and Trade Mark Office (DPMA) can be found at https://www.dpma.de/docs/english/formulare/patent_eng/p2799_1.pdf

DO

Artículo 27 de la Ley 20-00 sobre Propiedad Industrial: 1. Que el ajuste sea solicitado por el titular de la patente; 2. Que se haya producido un retraso irrazonable en el otorgamiento de la patente; 3. Que para configurar un retraso irrazonable por lo menos se incluya una demora en exceso de 5 años a partir de la fecha de solicitud o de 3 años a partir de la fecha del examen de fondo, cualquiera que sea posterior. 4. Que la solicitud sea presentada por el titular de la patente dentro del plazo de sesenta (60) días a partir de la expedición de la patente.   5. Que en el cálculo de los tiempos no se incluyan aquellas demoras imputables al solicitante.

EA

Requirements for granting a PTE: the Eurasian patent has to be in force; the product has been subject to the authorization to place it on the market of the Eurasian Patent Convention Contracting State (EAPC Contracting State); the product identified in the authorization to place on the market is protected by the Eurasian patent; the authorization issued by the competent authority of an EAPC Contracting State is the first authorization to place the product on the market of this State

EE

The product is protected by a patent in force; the product has been subject to a regulatory review procedure before its commercial use.

ES

a) el producto está protegido por una patente de base en vigor; b) el producto ha obtenido una autorización de comercialización vigente; c) el producto no ha sido objeto ya de un certificado; d) la autorización mencionada en la letra b) es la primera autorización de comercialización del producto

FR

Le certificat est délivré, si, dans l'État membre où est présentée la demande visée à l'article 7 et à la date de cette demande: a) le produit est protégé par un brevet de base en vigueur; b) le produit, en tant que médicament, a obtenu une autorisation de mise sur le marché en cours de validité conformément à la directive 2001/83/CE ou à la directive 2001/82/CE  suivant les cas; c) le produit n'a pas déjà fait l'objet d'un certificat; d) l'autorisation mentionnée au point b) est la première autorisation de mise sur le marché du produit, en tant que médicament.

GB

(a) that the product is protected by a basic patent in force (b) that a valid authorization has ben granted for the product (c) the product has not already been the subject of a certificate and (d) the authorization referred to in (b) is the first authorization to place the product on the market

HR

(a) the product is protected by a basic patent in force; (b) a valid authorisation to place the product on the market as a medicinal product has been granted in accordance with Directive 2001/83/EC or Directive 2001/82/EC, as appropriate; (c) the product has not already been the subject of a certificate; (d) the authorisation referred to in point (b) is the first authorisation to place the product on the market as a medicinal product. For now, we have avalaible only guidelines in croatian: https://www.dziv.hr/hr/prirucnik-za-ispitivanje-patenata/dio-g/

IT

the product has been protected by a patent, the product has been subject to an autorisation procedure before its commercial marketing or use, the filing date of the extension is on time

JP

https://www.jpo.go.jp/tetuzuki_e/t_tokkyo_e/files_guidelines_e/09_0100_e.pdf

KR

As a patented invention by Article 7 of the Enforcement Decree of the Patent Act (Invention Subject to Application for Registration of Patent Term Extension for Approval, etc.), 1. Invention of a medicine for which an approval by item has been granted pursuant to Article 31 (2), (3) or 42 (1) of the Pharmaceutical Affairs Act to practice a patented invention [limited to a medicine for which an approval by item has been granted first, among medicines manufactured with a new substance (referring to a substance whose chemical structure in the activated part having medicinal effects is new) as an effective ingredient]; or 2. Invention of an agricultural chemical or raw material registered pursuant to Article 8 (1), 16 (1), or 17 (1) of the Pesticide Control Act to practice a patented invention (limited to an agricultural chemical or raw material registered first, among agricultural chemicals and raw materials manufactured with a new substance as an effective ingredient). The scope of the patent claims shall include the item(s) approved pursuant to the Pharmaceutical Affairs Act or the item(s) registered pursuant to the Pesticide Control Act. Patents seeking to register an extension of its term shall be valid at the time of applying for the registration of the extended term of the patents. (A link to guidelines on filing applications for PTEs:: http://www.kipo.go.kr/kpo/user.tdf?a=user.html.HtmlApp&c=8044&catmenu=m11_02_06)

MD

LAW on the Protection of Inventions  No. 50-XVI of March 7, 2008 Article 71. Conditions for Grant of a Certificate a) the product is protected by a basic patent valid in the Republic of Moldova; b) the product was granted an effective authorization for marketing as a medicinal or phytopharmaceutical product; c) the product is not yet a subject-matter of a certificate in the Republic of Moldova; d) the authorization mentioned in letter b) is the first authorization for marketing in the Republic of Moldova of the respective product as a medicinal or phytopharmaceutical product. http://agepi.gov.md/sites/default/files/law/national/l_50_2008-en.pdf

RU

the product has been protected by a patent, the product has been subject to a regulatory review procedure before its commercial marketing or use, an SPC or PTE has never been granted on the product. 1) https://rupto.ru/ru/documents/prikaz-minekonomrazvitiya-rossii-ot-03-11-2015-810#adm_reg 2) https://rupto.ru/ru/documents/prikaz-minekonomrazvitiya-rossii-ot-03-11-2015-09#poryadok

SE

A certificate shall be granted a medicinal product if, the application is submitted and at the date of that application a)the product is protected by a basic patent in force; b)a valid authorisation to place the product on the market as a medicinal product has been granted in accordance with Directive 2001/83/EC or Directive 2001/82/EC, as appropriate; c) the product has not already been the subject of a certificate; d) the authorisation referred to in point (b) is the first authorisation to place the product on the market as a medicinal product. A certificate shall be granted a plant protection product if, the application is submitted and at the date of that application a)the product is protected by a basic patent in force; b) a valid authorization to place the product on the market as a plant protection product has been granted in accordance with Article 4 of Directive 91 /414/EEC or an equivalent provision of national law; c) the product has not already been the subject of a certificate; (d) the authorization referred to in (b) is the first authorization to place the product on the market as a plant protection product.

SK

A certificate shall be granted if the application referred to in Article 7 of the Regulation (EC) No 469/2009 and of the Regulation (EC) No 1610/96 of the European Parliament and of the council is submitted and at the date of that application: a) the product is protected by a basic patent in force; b) a valid authorisation to place the product on the market has been granted; c) the product has not already been the subject of a certificate; d) the authorisation referred to in point (b) is the first authorisation to place the product on the market. https://www.indprop.gov.sk/?what-is-a-supplementary-protection-certificate

UA

the product has been protected by a patent, the product has been subject to a regulatory review procedure before its commercial marketing or use, PTE has never been granted on the product. "Instructions on the procedure for extending the term of a patent for an invention" https://zakon.rada.gov.ua/laws/show/z0453-02?lang=en

US

https://www.uspto.gov/web/offices/pac/mpep/mpep-2700.html

4. Please specify the legal basis for granting SPCs or PTEs.  For example, relevant provisions of the national law (article or rule number), regional regulation, decrees, ordinances etc. If legal grounds are different for the objects indicated in Question 3, please list all of them, indicating corresponding products.

ST.3 Code Response
AU

As per question 3 above

BE

Règlement 469/2009, Règlement 1610/96, articles XI.92 à 103 du Code de droit économique, arrêté royal du 4 septembre 2014 relatif à la mise en oeuvre des dispositions relatives aux certificats complémentaires de protection de la loi du 19 avril 2014 portant insertion du livre XI, " Propriété intellectuelle " dans le Code de droit économique et portant insertion des dispositions propres au livre XI dans les livres I, XV et XVII du même Code

BR
CA

Sections 104 to 134 of the Patent Act and the Certificate of Supplementary Protection Regulations.

CH

Medicinal products: Art. 140a-140y Patents Act, Art. 127a-127z quinquies. For plant protection products: Art. 140z Patents Act, Art. 127zsexies-127z septies

CN
CO

Decreto 1873 de 2014

CR

Artículo 17 incisos 2 a 5 de la Ley de patentes de invención, dibujos y modelos industriales y modelos de utilidad, N° 6867

CZ

EU legislation - Regulations

DE

European Union Regulations (EC) No 469/2009 (medicinal products) and (EC) No 1610/96 (plant protection products) are directly applicable in Germany via Sections 16a and 49a of the German Patent Act (unofficial translation at https://www.gesetze-im-internet.de/englisch_patg/englisch_patg.html ).

DO

Artículo 27 Ley 20-00 sobre Propiedad Industrial

EA

Rule 16(5) of the Patent Regulations under the Eurasian Patent Convention

EE

Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products; Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products.

ES

Reglamento (CE) nº 469/2009 del Parlamento Europeo y del Consejo de 6 de mayo de 2009 relativo al certificado complementario de protección para los medicamentos; Reglamento (CE) nº 1610/96 del Parlamento Europeo y del Consejo de 23 de julio de 1996 por el que se crea un certificado complementario de protección para los productos fitosanitarios; Ley 24/2015, de 24 de julio, de Patentes (Art. 45-47) y Real Decreto, de 1 de abril de 2017, por el que se aprueba el Reglamento para la ejecución de la Ley 24/2015 (Art. 54-57) para ambas modalidades de CCP.

FR

règlement (CE) 469/2009, règlement (CE) 1610/96, règlement (CE) 1901/2006

GB

Article 3 Regulation (EC) 469/2009 of the European Parliament and Council concerning medicinal products and Regulation (EC) No 1610/96 of the European Parliament and Council concerning plant protection products

HR

National law: Patent Act and the Act on amending the Patent Act (OG No. 173/2003, 87/2005, 76/2007, 30/2009, 128/2010, 49/2011, 76/2013, 46/2018): Articles 1.a and 87.a to 87.l; Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products; Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products

IT

Legge 19 ottobre 1991, n. 349, Art.81, Art,61

JP

Patent Act Article 67(2), Article 67-2, Article 67-2-2, Article 67-3, Article 67-4

KR

·Article 89, 90, 91, 92, 93 of the Patent Act; Article 7 of the Enforcement Decree of the Patent Act; Article 52, 53 of the Enforcement Rules of the Patent Act; Operating Rules about Patent Term Extension for Approval, etc. (Notification No. 2018-29 of the Korean Intellectual Property Office) ·Drugs: Article 31 and 42 of the Pharmaceutical Affairs Act ·Pesticides: Article 8, 16 and 17 of the Pesticide Control Act

MD

LAW on the Protection of Inventions  No. 50-XVI of March 7, 2008 Article 69-72 and REGULATIONS on the Procedure of Filing and Examination of a Patent Application and of Grant of a Patent article 426-440

RU

the Civil code of the Russian Federation (Art. 1363, par. 2,4)

SE

Article 9 and 10 Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products. Article 9 and article 10 Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products.

SK

Article 3 of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products and Article 3 of Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996 concerning the creation of a supplementary protection certificate for plant protection products

UA

Part 4 of the article 6 of the Law of Ukraine "On the Protection of Rights to Inventions and Utility Models" http://www.uipv.org/i_upload/file/law-special-1.pdf ; article 220 "Association Agreement between the European Union and its Member States, of the one part, and Ukraine, of the other part" https://www.kmu.gov.ua/storage/app/media/uploaded-files/ASSOCIATION%20AGREEMENT.pdf ;  Instructions on the procedure for extending the term of a patent for an invention https://zakon.rada.gov.ua/laws/show/z0453-02?lang=en

US

35 U.S.C. 156 Legal Authority for Extension of Patent Term https://www.govinfo.gov/content/pkg/USCODE-2017-title35/html/USCODE-2017-title35-partII-chap14-sec156.htm

5. Please give the name(s) of the SPCs or PTEs granted by your Office/Organization in both English and the original language. Example:  DE – Supplementary Protection Certificate (in German  “Ergänzendes Schutzzertifikat”). If names are different for the products indicated in Question 3, please list all of the protections, indicating corresponding products.

ST.3 Code Response
AU

Extension of Term

BE

Supplementary Protection Certificate for medicinal products (en français : "Certificat Complémentaire de Protection pour les médicaments ; en néerlandais : "Aanvullend beschermingscertificaat voor geneesmiddelen") ; Supplementary Protection Certificate for plant protection products (en français : "Certificat Complémentaire de Protection pour les produits phytopharmaceutiques" ; en néerlandais : "Aanvullend beschermingscertificaat voor gewasbeschermingsmiddelen) ; Extension of the duration of the Supplementary Protection Certificate for medicinal products (en français : "Prorogation d'un Certificat Complémentaire de Protection pour les médicaments" ; en néerlandais : "Verlenging van een Aanvullend beschermingscertificaat voor geneesmiddelen")

BR
CA

Original in English: "Certificate of Supplementary Protection", Original in French: "Certificat de protection supplémentaire"

CH

DE/FR/IT - Supplementary protection certificates for medicinal products (German: Ergänzende Schutzzertifikate für Arzneimittel; French: Certificats complémentaires de protection par les médicamants; Italian: Certificati protettivi complementari per medicinali). DE/FR/IT -Pediatric supplementary protection certificates for medicinal products (German: Pädiatrische ergänzende Schutzzertifikate für Arzneimittel; French: Certificats complémentaires de protection pédiatriques pour les médicaments; Italian: Certificati protettivi complementari pediatrici per medicinali). DE/FR/IT - Supplementary protection certificates for plant protection products (German: Ergänzende Schutzzertifikate für Pflanzenschutzmittel; French: Certificats supplémentaires de protection pour les produits phytosanitaires; Italien: Certificati protettivi complementari per prodotti fitosanitari)

CN
CO

Compensación del plazo de duración de la patente mediante restauración

CR

Compensation in the term of the patent (español: Compensación en el plazo de vigencia de la patente)

CZ

CZ - Supplementary Protection Certificate (in Czech: "Dodatkové ochranné osvědčení"). Abbreviations: "SPC" and/or "DOO"

DE

DE-Supplementary Protection Certificate (German "Ergänzendes Schutzzertifikat")

DO

Certificados de compensación del plazo de vigencia de las patentes de invención/ compensation of the term of validity of the patents of invention.

EA

EA – "Annex to the Eurasian patent" (in Russian: "Приложение к евразийскому патенту")

EE

Supplementary Protection Certificate (in Estonian "täiendava kaitse tunnistus".

ES

Supplementary Protection Certificate for medicinal products (en español: "Certificado Complementario de Protección para medicamentos"); Supplementary Protection Certificate for plant protection products (en español: "Certificado Complementario de Protección para productos fitosanitarios").

FR

certificat complémentaire de protection

GB

Supplementary protection certificate, there is no difference in name for each of the products listed in 3

HR

in English - Supplementary Protection Certificate; in Croatian - Svjedodžba o dodatnoj zaštiti

IT

Supplementary Protection Certificate (Certificato complementare di protezione)

JP

JP- Extension of Patent Term (in Japanese "特許権の存続期間の延長")

KR

KR – Patent Term Extension for Approval, etc. (in Korean: "허가등에 따른 특허권존속기간 연장등록출원")

MD

In English - Supplementary Protection Certificate, in Romanian - Certificat Complementar de Protectie

RU

RU – ADDITIONAL PATENTS OF THE RUSSIAN FEDERATION FOR INVENTIONS (Дополнительный патент на изобретение )

SE

SE - Supplementary Protection Certificate (in Swedish: "Tilläggsskydd", (SPC))

SK

SK - Supplementary Protection Certificate (in Slovak: "Dodatkové ochranné osvedčenie")

UA

UA - Extension of the validity period of the patent for an invention, the object of which is a medicinal product, a means of animal protection, a plant protection, etc (in Ukraine: "Продовження строку дії патенту на винахід, об'єктом якого є лікарський засіб, засіб захисту тварин, засіб захисту рослин тощо" (A separate certificate is not given, but the entry is made in the Register and the corresponding publication in the official bulletin is made).

US

Certificate Extending Patent Term under 35 USC 156

6. If your Office/Organization assigns (or intends to assign) a specific application and/or grant/registration number to SPCs or PTEs, please give examples and details of

ST.3 Code The numbering system for applications The numbering system for registration or grant (if different) Comments
AU

AU does not assign (or intend to assign) a specific grant/application/registration number

BE

2018C/001 ; 2018C/501

Le numéro correspondant à la demande de certificat est identique au numéro correspondant au certificat délivré.   Les 4 premiers chiffres indiquent l'année d'introduction de la demande.   La lettre "C" qui suit indique qu'il s'agit d'un certificat.   Les 3 numéros suivants (séparés par "/") indiquent le numéro du dossier. Ils progressent de manière croissante au fur et à mesure que les demandes sont introduites au cours d'une année.   Les numéros de 001 à 499 sont réservés aux demandes introduites physiquement tandis que les numéros 501 à 999 sont réservés aux demandes introduites par voie électronique.

BR
CA

the first Certificate of Supplementary Protection application was numbered "900001", and subsequent applications are numbered in chronologically increasing order

CH

[Hilfe und Beispiele aufrufen] C685436/01, C00740668/01

The letter "C", followed by the Number of the CH or EP Patent, followed by "/" followed by a serial number starting with 01 for the first SPC with the same patent as a base patent

CN
CO

No se ha previsto hasta la fecha.

CR

El sistema le asigna una referencia.

El sistema le asigna una referencia.

República de Costa Rica Registro Nacional Registro de la Propiedad Industrial Compensación de Plazo de Vigencia Ref: 30/2019/398  Expediente: Inscripción de Patente PCT N°. y fecha: 2012- 0000510 de 08/10/2012 Título: DERIVADOS DE PIPERIDIN-4-IL AZETIDINA COMO INHIBIDORES DE JAK1 Titular:        INCYTE HOLDINGS CORPORATION N°. Registro: 3672

CZ

SPC/CZYYYY/number series

Patent number/SPC number series

Examples: Application (INID Code 21): SPC/CZ2018/605 Granted (INID Code 11): 1641823/404

DE

Since 1st January 2004 in DE:  Two digit identification number (12 for SPCs), followed by four digit year of application (e.g. 2018), followed by six digit annual serial number (e.g. 000011 for the 11th application in the respective year), followed by full stop followed by error checking number (calculated from the numbers before full stop). Example: DE 12 2018 000 011.6

Since 1st January 2004 in DE:  Two digit identification number (12 for SPCs), followed by four digit year of application (e.g. 2018), followed by six digit annual serial number (e.g. 000011 for the 11th application in the respective year), followed by full stop followed by error checking number (calculated from the numbers before full stop). Example: DE 12 2018 000 011.6 Granted SPCs keep same number as indicated above for application.

DO
EA

Number of the Eurasian patent/serial number of the PTE for this patent/two-letter code of the EAPC Contracting State

The PTE is granted for each EAPC Contracting State (e.g. 000474/2/KZ – the term of the Eurasian patent №000474 is extended in the Republic of Kazakhstan and this is the second extension of this patent's term)

EE

C20010001

00001

Application No - YYYY 0000N; registration No - countinous numbering

ES

C aaaannnnn (solicitudes en formato papel); C aaaa3nnnn (solicitudes en formato electrónico)

Ejemplos: C 201700001 (solicitudes en formato papel); C 201730001 (solicitudes en formato electrónico)

FR

18C1001

Millésime de l'année de dépôt, suivi de C et du numéro de dépôt précédé de 10 pour un dépôt électronique. Antérieurement à l'obligation de déposer sous forme électronique, le dépôt sous forme papier remplaçait 10 par 00 (ex : 17C0001)

GB

SPC/GB/YY/NNN wherein YY is the two figure year and NNN is the number starting from 001 for the first application filed in the relevent calender year

same as above, the application number is retained for the granted SPC

HR

S20130001A

S20130001

Application and grant numbers start with S, followed by four digits for year and four digits for the ordinal number of the filing in the year. Grant number does not have letter A in the end.

IT

13YYYYnnnnnnnnn (Supplementary Protection Certificate for medicinal), 14YYYYnnnnnnnnn (Supplementary Protection Certificate for fitosanitary)

JP

2018-7000001

The application number starts from 700001.  JPO doesn't assign a grant/registration number.

KR

The numbering system is the same with that for general applications.

The original registration number is used, but the items relating to Patent Term Extension for Approval, etc. including the final expiry date of the patent term shall be added to the Patent Register when a decision is made to register an extension of the term of a patent right.

MD

c 2019 0001

MD M 0001

RU

Special numbers are not assigned

SE

SPC: YY900NN-C, SPC-F: YY9M0NN-C

YY = year N = sequence numbering 0,...,9 M = sequence numbering 1,...,9 C = check sum 0,...,9 SPC-F means "extension of SPC"

SK

PDO nnnnn-yyyy (for example PDO 00027 -2018

DO nnnnn (for example DO 257)

UA
US

There is no unique number assigned for the Certificate, it is associated with the patent no.

7. Does your Office/Organization or other relevant national authority publish, or intend to publish, one or more of the following events for an SPC or PTE?

ST.3 Code Request (application) for an SPC or PTE filed SPC or PTE granted SPC or PTE not granted SPC or PTE opposed by third parties SPC or PTE came into force SPC or PTE ceased because of a lapse or expiry Extension of SPC term requested Extension of SPC term granted Extension of SPC term not granted Comments
AU

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

BE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

OTHER

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

En ce qui concerne la contestation par des tiers, ceux-ci ont la possibilité des déposer des observations auprès de notre Office en cours de procédure. Ces observations ne sont pas publiées mais ne lient pas non plus l'Office dans son appréciation ; il ne s'agit donc pas d'une réelle possibilité de contestation.  Le seul moyen, pour un tiers, de réellement s'opposer à un certificat consiste à introduire une action devant les Cours et Tribunaux en Belgique une fois que le certificat aura été délivré. Ceux-ci pourront annuler le certificat délivré au motif qu'il ne répondait pas aux conditions de délivrance.  L'information selon laquelle un certificat fait l'objet d'une procédure devant les Cours et Tribunaux n'est publiée par l'Office que si elle lui a été valablement notifiée par une partie intéressée.

BR
CA

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

Lapse (no), expiry (yes)

CH

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

CN
CO

La Oficina no ha tenido la primera solicitud de  compensación del plazo de duración de la patente mediante restauración.

CR

En caso de que la compensación se solicite previo a la emisión del certificado de inscripción, se publica una referencia junto con la inscripción en la que consta el plazo extendido.

CZ

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

DE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

There are no opposition proceedings for SPCs in Europe (cf. Art.19 (2) of Regulation (EC) No 469/2009). Invalidity actions against granted SPCs and revocation actions against extensions of SPC term are available (cf. Articles 15 and 16 of Regulation (EC) No 469/2009). Filing of a nullity/revocation action and the ultimate decision is published.

DO

Hasta la fecha no hemos contemplado publicar las incidencias relativas a los CCP o las PTE.

EA

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

EE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

ES

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

FR

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

OTHER

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

GB

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

HR

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

Data on when SPC came into force it will be visible in our online database at the end of 2019 as a first date in period of validity

IT

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

JP

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

KR

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

Application for a PTE filed - Patent Gazette; PTE granted - Publication of Registration; PTE opposed by third parties - Patent Register; PTE came into force - Patent Register; PTE ceased because of a lapse or expiry - Patent Register

MD

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

RU

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

SE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

See example: https://was.prv.se/spd/spc?lang=en&hits=true&spcnummer=+0190035-6&spcsystem=EP&hitsstart=0&tab=4&number=01900356&start=0

SK

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

UA

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

OTHER

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

OTHER

US

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

8a. In what form is the corresponding event published?

ST.3 Code Response Indicate the name and the URL of the database Other (please specify)
AU

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

BE

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

https://bpp.economie.fgov.be/fo-eregister-view/

BR
CA

through public online databases (please indicate the name and the URL of the database)

Register of Certificates of Supplementary Protection and Applications. URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/register-certificates.html Registre des certificats de protection supplémentaire et des demandes. URL : https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/registre-certificats.html

CH

through public online databases (please indicate the name and the URL of the database)

Swissreg (URL for SPC: https://www.swissreg.ch/srclient/faces/jsp/spc/sr1.jsp)

CN
CO
CR
CZ

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

web of the IPO CZ / Patents / SPCs ;  https://upv.cz/en/client-services/online-databases.html

DE

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

DPMAregister (https://register.dpma.de/DPMAregister/pat/einsteiger)

DO
EA

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

https://www.eapo.org/ru/publications/publicat/publicat.php (Eurasian Publication Server)

https://www.eapo.org/ru/?patents=reestr (Register of Eurasian Patents)

EE

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

https://www.epa.ee/en/databases/inventions-databases

ES

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

http://consultas2.oepm.es/ceo/

FR

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

www.inpi.fr

GB

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

See for example data for SPC/GB12/034 comprising bibliographic data :https://www.ipo.gov.uk/p-find-spc-bypatent-results.htm?number=EP0783893; and lifetime data https://www.ipo.gov.uk/p-ipsum/Case/PublicationNumber/EP0783893

HR

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

it will be possible at the end of 2019 at https://www.dziv.hr/en/e-services/on-line-database-search/

IT

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

http://www.uibm.gov.it/bancadati/

by delivering a copy of the file on reques

JP

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

https://www.j-platpat.inpit.go.jp/web/all/top/BTmTopEnglishPage

KR

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

KIPO Homepage – Notice – Internet Bulletin – Other Information Including Service by Public Notice, etc. – Patent Term Extension (http://www.kipo.go.kr/kpo/user.tdf?a=user.html.HtmlApp&c=4020&catmenu=m03_03_08); or Original application information on KIPRIS (http://eng.kipris.or.kr/enghome/main.jsp)

MD

as part of an Official Gazette

by opening the document for public inspection

RU

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

http://www1.fips.ru/wps/portal/ofic_pub_ru/#

SE

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

Swedish Patent Database: https://was.prv.se/spd/search?tab=4&lang=en, Detaild information: https://was.prv.se/spd/spc?lang=en&hits=true&spcnummer=+0190035-6&spcsystem=EP&hitsstart=0&tab=4&number=01900356&start=0

The information that an SPC has entered into force is not published in the Official Gazette, but it may be seen through the the other forms of publication mentioned above.

SK

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

WEB REGISTERS - https://wbr.indprop.gov.sk/webregistre/

UA

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

http://base.uipv.org/searchBul/search.php?action=viewnotices&dbname=inv&sid=8c78b4e4a7eb1450ab1f7585972ccace

US

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

Public PAIR and https://www.uspto.gov/patent/laws-and-regulations/patent-term-extension/ patent-terms-extended-under-35-usc-156

Also published in the patents image public database in the Corrections section of the document

8b. What are the minimum elements that this publication must contain?

ST.3 Code Response Other elements (please specify)
AU

filing date

name and address of the applicant

number of the relevant patent

title of the invention

date of the SPC or PTE authorization

BE

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

Le cas échéant, l'indication que la demande de certificat inclut une demande de prorogation ; la durée du certificat ; le cas échéant, la mention du rejet de la demande et, le cas échéant, l'extinction, la révocation ou l'annulation du certificat

BR
CA

number of the relevant patent

patent expiry date, medicinal ingredient(s), human or veterinary use, number of the authorization for sale, certificate of supplementary protection (CSP) number, the day on which the CSP term begins and on which its term ends

CH

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

expiration date of the protection

CN
CO
CR
CZ

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

DE

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

DO
EA

number of the relevant patent

name of the product

proprietor name; date of publication of the Eurasian patent; date of expiry of the PTE; indication of the EAPC Contracting State in respect to which the PTE is granted

EE

application number

filing date

name and address of the applicant

number of the relevant patent

legal status

ES

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

Representante; Fecha límite de validez del CCP; Fecha de la concesión del CCP

FR

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

datr d'expiration, révocation de la prorogation

GB

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

HR

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

IT

application number

filing date

name and address of the applicant

number of the relevant patent

name of the product

authorization details

date of the SPC or PTE authorization

JP

application number

filing date

name and address of the applicant

extension period, registration number, date of registration of extension, the period for which the extension is requested

KR

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

The name and address of a patentee (if a patentee is a corporation, its name and place of business) when a decision is made to register extension of the term of a patent right; Number of the relevant patent:: Original application number and original patent number; The claim numbers for which the term is to be extended; The number of the claims for which the term is to be extended; The name and address or place of business of a patent attorney or agent; The expiry date of the patent term (The final expiry date of the patent term when a decision is made to register extension of the term of the patent right); The requested term of which is to be extended (The extended patent term when a decision is made to register extension of the term of the patent right)

MD

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

RU

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

Serial number of SPC; number and date of the first national authorization to place the product on the market as a medicinal product or plant protection product;  the date concerning the application for an extension of the duration, the revocation of an extension of the duration and the recalculation of the duration; Calculated date of expiry of the SPC or the duration of the SPC; the date of the entry to the state register

SE

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

SK

application number

filing date

name and address of the applicant

number of the relevant patent

title of the invention

name of the product

authorization details

date of the SPC or PTE authorization

UA

number of the relevant patent

expected expiration date of the patent

US

number of the relevant patent

name of the product

authorization details

date of the SPC or PTE authorization

Original expiry date of the patent as of the grant of the PTE. Duration of Extension

8c. What is the planned timetable for publishing this information?

ST.3 Code Response
AU
BE

Il n'y a pas de délai légalement prévu. En pratique, la publication dans notre Registre intervient en principe le lendemain du jour où les informations sont encodées dans notre système.

BR
CA

The Register of Certificates of Supplementary Protection and Applications and the Registre des certificats de protection supplémentaire et des demandes are already published and are updated as needed

CH

we are currently changing vom every 14 days to real time

CN
CO
CR
CZ

This information is already published.

DE

DPMAregister is updated overnight, publication in the Official Gazette ("Patentblatt" in Germany) can take up to 12 weeks.

DO
EA

Next Official Gazette (monthly publication)

EE

The database is updated on the publication date of the Estonian Patent Gazette each month.

ES

Ya se publica automáticamente dentro de un plazo de 4 días desde la resolución de la incidencia correspondiente mediante un sistema informático.

FR

aucun délai légal

GB

this information is currently published

HR

biweekly (Official Gazette)

IT

weekly

JP

Once a month

KR

[Application division] Formality check ==> [Application system] Request the publication of the patent gazette --> publish the patent gazette ==> [Examination division] The examiner makes a decision to register extension of the term of the patent right ==> [Registration system] Request the Publication of Registration --> publish the Registration

MD

within 2 months from the date of sending of the decision of grant the supplementary protection certificate

RU

Publication of the notification occurs immediately and automatically after the making an entry into the Public Register

SE

When it is notified in the Swedish Patent Gazette, weekly.

SK
UA

Twice a month

US

Once granted, the PTE certificate is appended to the patent grant image.

8d. Please attach an example(s) of published events and/or of corresponding announcements.

ST.3 Code Response Comments
AU

Please see AUSPAT

BE

Voyez le Registre public à l'adresse suivante : https://bpp.economie.fgov.be/fo-eregister-view/ ; Voyez aussi le Bulletin officiel à l'adresse suivante : https://economie.fgov.be/fr/themes/propriete-intellectuelle/brevets/recueil-des-brevets-dinvention

BR
CA

https://app.surveygizmo.com/response/download/file/64-7f8252a34c0567aabe44f43cd60342cc_reg-cert-sup-eng.pdf/id/4649820

https://app.surveygizmo.com/response/download/file/250-d38adb33bf9299aa9df0cd1d0d4d466d_reg-cert-sup-fra.pdf/id/4649820

CH

https://app.surveygizmo.com/response/download/file/118-ded5522e1ec9a081f84ece888f8ef049_2019-01-29_detailansicht_esz.pdf/id/4649820

CN
CO
CR
CZ

https://isdv.upv.cz/doc/vestnik/2018/vestnik_UPV_201846.pdf Example 1, Request for SPC: (22) 10.10.2018 (21) SPC/CZ2018/606 (71) Novartis AG, 4056 Basel, CH (68) 2902039 (54) Antagonistické protilátky proti IL-17 (92) EU/1/14/980, 23.11.2015 (93) EU/1/14/980, 23.11.2015, EU (95) Cosentyx - secukinumab, léčivý přípravek,  Example 2, SPC granted: (73) ELI LILLY AND COMPANY, Indianapolis, IN 46285, US (68) 1641823 (11) 1641823/404 (54) Fúzní proteiny GLP-1 analogu (92) EU/1/14/956, 25.11.2014 (93) EU/1/14/956, 25.11.2014, EU (95) Trulicity-dulaglutidum, léčivý přípravek (94) 10.06.2029

DE

https://app.surveygizmo.com/response/download/file/250-7b616ecc64ba3d0fa69d05939d9d669b_DPMAregister__Patente_-_Registerauskunft_12_2007_000_033.pdf/id/4649820

https://app.surveygizmo.com/response/download/file/195-f9121fba272eb8bbc84e13f9ab24a260_PAT_1220050000418_2019-01-25.pdf/id/4649820

DO
EA

https://app.surveygizmo.com/response/download/file/250-e8a8e98e551d456b69a6be4269b6f5e2_Gazette.png/id/4649820

https://app.surveygizmo.com/response/download/file/54-2b394805e52e228145cdc842f9fe8aef_Publication_Server.png/id/4649820

https://app.surveygizmo.com/response/download/file/137-1af4b86d78c51ca851eb6584a7cf5c42_Patent_register.png/id/4649820

EE

Patent Gazette: https://www.epa.ee/sites/www.epa.ee/files/elfinder/dokumendid/patendileht2019_01.pdf (find a relevant part of the Patent Gazette)

ES

https://app.surveygizmo.com/response/download/file/238-1765f20e6dcb85e3621115463226fc80_Ejemplos_de_publicaci%C3%B3n_de_incidencias.pdf/id/4649820

FR

https://bases-brevets.inpi.fr/fr/document/FR16C0001.html?p=5&s=1545038793916&cHash=f2994d022820e27a351f55b334a09ef7 https://bases-brevets.inpi.fr/fr/document/FR16C0001/publications.html?p=5&s=1545038793916&cHash=b865e7b3c95ef7ae0b6300103d08e28b https://bases-brevets.inpi.fr/fr/document/FR16C0001/publications.html?p=5&s=1545038793916&cHash=b865e7b3c95ef7ae0b6300103d08e28b https://bases-brevets.inpi.fr/fr/document/FR15C0097/publications.html?p=5&s=1545038914470&cHash=6f17c973b229aeee6227a3b3acc21902

GB

https://app.surveygizmo.com/response/download/file/130-76fe90a44b1ebb3e457c1cfff310671b_patents_journal_example.pdf/id/4649820

HR

https://app.surveygizmo.com/response/download/file/202-95e1c1ce9b35b8e7e500e7dc6968e6ac_SPC_example1.pdf/id/4649820

IT

https://app.surveygizmo.com/response/download/file/249-e270da1f92d692b554a437441182de1b_EXAMPLE_CCP.pdf/id/4649820

JP

https://app.surveygizmo.com/response/download/file/202-6b35cbe836b715aa340b923e1893eb94_JPO_sample.pdf/id/4649820

(Request (application) for an SPC or PTE filed ) The publication doesn't contain "extension period","date of registration of extension". (SPC or PTE granted) The publication doesn't contain "the period for which the extension is requested".

KR

https://app.surveygizmo.com/response/download/file/37-bf9473406925fa7d102d9d6080156a5e_Patent_gazette.png/id/4649820

https://app.surveygizmo.com/response/download/file/188-93a594c89889f192ddcfa26a5a0b4c46_Registration.png/id/4649820

MD

In the Republic of Moldova at the moment we do not have any medicinal products protected by a complementary protection certificate

RU

https://app.surveygizmo.com/response/download/file/238-cacf4670151fe0bc950aef1649b7e274_SPC.PDF/id/4649820

https://app.surveygizmo.com/response/download/file/202-693fe32c435116d03d1a35379f2e3dbb_Notification.PDF/id/4649820

The first file is an example of the additional patent (SPC), the second one is an example of the notification.

SE

https://was.prv.se/spd/spc?lang=en&hits=true&spcnummer=+0190035-6&spcsystem=EP&hitsstart=0&tab=4&number=01900356&start=0

SK

https://app.surveygizmo.com/response/download/file/198-8e4b6c1d107c4d94c234c17ae950cedf_example_request_for_the_SPC_filed_Official_Gazette.png/id/4649820

https://app.surveygizmo.com/response/download/file/202-7b204ab02b1d773010273414664808cc_example_SPC_granted_Official_Gazette.png/id/4649820

https://app.surveygizmo.com/response/download/file/195-2304fa89ffbc36dcdf836ad3b12f9604_example_extension_of_SPC_term_granted_Official_Gazette.png/id/4649820

UA

https://app.surveygizmo.com/response/download/file/238-b7ffed99bf7c08a87105c5324b99b4ad_Published_event.doc/id/4649820

published as event "Extension of the validity period of the patent for an invention, the object of which is a medicinal product, a means of animal protection, a plant protection, etc"

US

https://app.surveygizmo.com/response/download/file/195-399992ac8327a5018be1f8ab0931fceb_US_question_8d.pdf/id/4649820

see attachment

9. Does your Office/Organization or other relevant national authority publish (or intend to publish) the announcement of state changes for an SPC or PTE as defined in WIPO Standard ST.27?

ST.3 Code Changed to “Active” Changed to “Not active” Changed to “Terminated”
AU
BE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

BR
CA

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

MEDICINAL PRODUCTS

CH
CN
CO
CR
CZ

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

DE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

DO
EA
EE

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

ES
FR

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

GB

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

HR

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

IT
JP
KR
MD
RU

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

SE
SK

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

MEDICINAL PRODUCTS

PLANT PROTECTION PRODUCTS

UA
US

10a. In what form is the announcement related to the state change published?

ST.3 Code Response Indicate the name and the URL of the database Other (please specify)
AU
BE

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

https://bpp.economie.fgov.be/fo-eregister-view/

BR
CA

through public online databases (please indicate the name and the URL of the database)

gister of Certificates of Supplementary Protection and Applications URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/register-certificates.html Registre des certificats de protection supplémentaire et des demandes URL : https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/registre-certificats.html

CH
CN
CO
CR
CZ

through public online databases (please indicate the name and the URL of the database)

other (please specify):

https://isdv.upv.cz/webapp/!resdb.pta.frm

bulk data

DE

through public online databases (please indicate the name and the URL of the database)

DPMAregister (https://register.dpma.de/DPMAregister/pat/einsteiger)

DO
EA
EE

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

https://www.epa.ee/en/databases/inventions-databases

ES
FR

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering  a copy of the publication on request

other (please specify):

https://bases-brevets.inpi.fr

le cas échéant, inscription au registre

GB

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

https://www.ipo.gov.uk/p-ipsum/

HR

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

it will be possible at the end of 2019 at https://www.dziv.hr/en/e-services/on-line-database-search/

IT
JP
KR
MD
RU

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

http://www1.fips.ru/wps/portal/ofic_pub_ru/#

SE
SK

as part of an Official Gazette

through public online databases (please indicate the name and the URL of the database)

by opening the document for public inspection

by delivering a copy of the publication on request

https://wbr.indprop.gov.sk/WebRegistre/DodatkoveOchranneOsvedcenie/BasicSearch?HlaskaStav=VyhodHlasku&SearchCBO_PoslednyRokPlatnosti=False&SearchCBO_AktualnaPlatnostKonciNasledujuciMesiac=False&IsSearchSimilarMPT=True&IsSearchSimilarMTD=True&IsSearchSimilarMTOP=True&IsSearchSimilarPrihlasovatelovMajitelov=True&IsSearchSimilarPovodcov=True&IsSearchSimilarZnenieReprodukciuOZ=True&IsSearchSimilarCisloZakladnehoPatentu=True&ItemPPType=DodatkoveOchranneOsvedcenie&SearchType=NoSearch&Lang=en&SearchResultsMaxReached=False&HighlightSearchCriteria=True&SearchExternalDatabases=False&IsFulltextSearch=False&SearchTimeout=False

UA
US

through public online databases (please indicate the name and the URL of the database)

https://portal.uspto.gov/pair/PublicPair

10b. What are the minimum elements that this publication must contain?

ST.3 Code Response Other elements (specify)
AU
BE

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

other elements, e.g. patent classification (please specify):

Le cas échéant, l'indication que la demande de certificat inclut une demande de prorogation ; la durée du certificat ; le cas échéant, la mention du rejet de la demande et, le cas échéant, l'extinction, la révocation ou l'annulation du certificat

BR
CA

other elements, e.g. patent classification (please specify):

patent expiry date, medicinal ingredient(s), human or veterinary use, number of the authorization for sale, certificate of supplementary protection (CSP) number, the day on which the CSP term begins and on which its term ends

CH
CN
CO
CR
CZ

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

other elements, e.g. patent classification (please specify):

pediatric extension

DE

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

other elements, e.g. patent classification (please specify):

As ST.27 will be provided as additional information of the entry in the register, all information present in the register is available, i.e. classification, responsible department at the office, etc.

DO
EA
EE

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

name of the product

duration of the SPC or PTE

ES
FR

registration number allotted to the SPC or PTE, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

other elements, e.g. patent classification (please specify):

mention du rejet, notification de l'acceptation de la prorogation ou du rejet de la prorogation

GB

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

HR

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

IT
JP
KR
MD
RU

other elements, e.g. patent classification (please specify):

the date of termination

SE
SK

registration number allotted to the SPC or PTE, which has come into force

date of SPC or PTE registration, which has come into force

name and address of the SPC or PTE holder

number of the relevant patent

title of the invention

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

UA
US

number of the relevant patent

name of the product

authorization details

date of SPC or PTE authorization

duration of the SPC or PTE

other elements, e.g. patent classification (please specify):

Original expiry date of the patent as of the grant of the PTE

10c. What is the planned timetable for publishing this information?

ST.3 Code Response
AU
BE

Il n'y a pas de délai légalement prévu. En pratique, la publication dans notre Registre intervient en principe le lendemain du jour où les informations sont encodées dans notre système.

BR
CA

The Register of Certificates of Supplementary Protection and Applications and the Registre des certificats de protection supplémentaire et des demandes are already published and are updated as needed

CH
CN
CO
CR
CZ

Q2 2020

DE

Planned to go into production in 2019. Then: DPMAregister is updated overnight.

DO
EA
EE

The database is updated on the publication date of the Estonian Patent Gazette each month.

ES
FR

pas de délai légal

GB

We intend to implement ST.27 but this will be as part of our digital transformation program and therefore likely to be in 3-5 years minimum

HR

biweekly (Official Gazette)

IT
JP
KR
MD
RU

Continous publication

SE
SK
UA
US

10d. Please attach specimen(s) of corresponding announcements.

ST.3 Code Response
AU
BE
BR
CA

https://app.surveygizmo.com/response/download/file/188-9607f1d48341421f5900b55c580cae90_reg-cert-sup-eng.pdf/id/4649820

https://app.surveygizmo.com/response/download/file/198-dce2028cea328715f96fa3aac04173f6_reg-cert-sup-fra.pdf/id/4649820

CH
CN
CO
CR
CZ
DE
DO
EA
EE
ES
FR
GB
HR

https://app.surveygizmo.com/response/download/file/250-61cd3fdee8d5d910c2743cb71b94938e_SPC_example2.pdf/id/4649820

IT
JP
KR
MD
RU

https://app.surveygizmo.com/response/download/file/118-6544a795685aea3b372701a8dca0c962_Notification.jpg/id/4649820

https://app.surveygizmo.com/response/download/file/249-1e85ab30f15b3f916c5dd009b832c658_claim.jpg/id/4649820

https://app.surveygizmo.com/response/download/file/185-d1600d5bded6f3c92baf2ee8e97cffa1_SPC_claim.jpg/id/4649820

SE
SK

https://app.surveygizmo.com/response/download/file/132-e2d625c16fd8b98eb1154a16bfb29aaa_example_SPC_state-active_WebRegisters.png/id/4649820

https://app.surveygizmo.com/response/download/file/96-78b3f384146f2d4777c395ca8277150a_examples_states_active_and_not_active_item-10d.docx/id/4649820

UA
US